DE

459.16

-1.11%↓

CTAS

206.67

-1.07%↓

CPRT

60.86

-0.52%↓

CSX

27.92

+0.11%↑

PAYX

142.28

-0.78%↓

DE

459.16

-1.11%↓

CTAS

206.67

-1.07%↓

CPRT

60.86

-0.52%↓

CSX

27.92

+0.11%↑

PAYX

142.28

-0.78%↓

DE

459.16

-1.11%↓

CTAS

206.67

-1.07%↓

CPRT

60.86

-0.52%↓

CSX

27.92

+0.11%↑

PAYX

142.28

-0.78%↓

DE

459.16

-1.11%↓

CTAS

206.67

-1.07%↓

CPRT

60.86

-0.52%↓

CSX

27.92

+0.11%↑

PAYX

142.28

-0.78%↓

DE

459.16

-1.11%↓

CTAS

206.67

-1.07%↓

CPRT

60.86

-0.52%↓

CSX

27.92

+0.11%↑

PAYX

142.28

-0.78%↓

Search

Enovis Corp

Atidarymo kaina

SektoriusPramonės sektorius

35.05 2.76

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

34.05

Max

35.37

Pagrindiniai rodikliai

By Trading Economics

Pajamos

-672M

-703M

Pardavimai

56M

561M

Pelnas, tenkantis vienai akcijai

0.98

Pelno marža

-125.353

Darbuotojai

7,367

EBITDA

-602M

-590M

Rekomendacijos

By TipRanks

Rekomendacijos

Stiprus pirkimas

12 mėnesių prognozė

+78.56% upside

Dividendai

By Dow Jones

Kitas uždarbis

2025-05-08

Rinkos statistika

By TradingEconomics

Rinkos kapitalizacija

-782M

1.8B

Ankstesnė atidarymo kaina

32.29

Ankstesnė uždarymo kaina

35.05

Enovis Corp Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2025-01-07 23:28; UTC

Pagrindinės rinkos jėgos

Maplebear Up on S&P MidCap 400 Inclusion

Akcijų palyginimas

Kainos pokytis

Enovis Corp Prognozė

Kainos tikslas

By TipRanks

78.56% į viršų

12 mėnesių prognozė

Vidutinis 62.71 USD  78.56%

Aukščiausias 75 USD

Žemiausias 46 USD

Remiantis 8 „Wall Street“ analitikais, siūlančiais 12 mėnesių tikslines Enovis Corp kainas – Dist per pastaruosius 3 mėnesius.

Bendras įvertinimas

By TipRanks

Stiprus pirkimas

8 ratings

7

Pirkti

1

Laikyti

0

Parduoti

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

$

Apie bendrovę Enovis Corp

Enovis Corporation operates as a medical technology company focus on developing clinically differentiated solutions worldwide. It also manufactures and distributes medical devices which are used for reconstructive surgery, rehabilitation, pain management, and physical therapy. The company operates through Prevention and Recovery, and Reconstructive segments. Its Prevention and Recovery segment offers orthopedic solutions and recovery sciences including rigid and soft orthopedic bracing, hot and cold therapy, bone growth stimulators, vascular therapy systems and compression garments, therapeutic shoes and inserts, electrical stimulators management, and physical therapy products which are used by orthopedic specialists, surgeons, primary care physicians, pain management specialists, physical therapists, podiatrists, chiropractors, athletic trainers, and other healthcare professionals. The company's Reconstructive segment operates surgical implant business, which includes a suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and finger, as well as surgical productivity tools. The company distributes its products through independent distributors and directly under the ESAB and DJO brands. Enovis Corporation was formerly known as Colfax Corporation. The company was founded in 1995 and is headquartered in Wilmington, Delaware.